GlassScriptPhysician profile
Charles S Decarlo
NPI 1578912887
$10,618.86
in general payments reported to CMS, 2019-2025
25 companies · $2,125 in 2025
The $2,125 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $543 · 2021: $1,002 · 2022: $1,713 · 2023: $1,667 · 2024: $3,048 · 2025: $2,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,198 · Consulting Fee: $480 · Education: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,197.72 |
| Consulting Fee | $480.00 |
| Education | $162.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $2,524.73 | 2019-2025 | Zenith Spiral-Z, Cook, Zenith Alpha |
| W. L. Gore & Associates, INC. | $1,427.11 | 2021-2024 | Gore Tag Conformable Thoracic Endoprosthesis, C3 Delivery System, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $1,256.77 | 2023-2025 | 2cm Peripheral Cutting Balloon, Eluvia, General - Catheters |
| Penumbra, INC. | $784.10 | 2021-2025 | Indigo System, Penumbra System |
| Cagent Vascular INC | $610.00 | 2025 | Serrantor |
| Medtronic Vascular, INC. | $526.84 | 2019-2020 | |
| Surmodics, INC. | $503.12 | 2024 | Pounce LP Thrombectomy, Pounce Thrombectomy, Pounce Thrombectomy System |
| Silk Road Medical, INC. | $497.17 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Endologix LLC | $473.46 | 2019-2022 | |
| Medtronic, INC. | $426.70 | 2024 | Chocolate Pta Balloon Catheter, Ellipsys Vascular Access System, Hawkone |
| Inari Medical, INC. | $418.21 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cvrx, INC. | $255.59 | 2024 | Barostim Neo System |
| Cardiovascular Systems INC. | $245.10 | 2020-2021 | |
| Philips North America LLC | $118.15 | 2024 | (6578) Visions 018 |
| Shockwave Medical, INC | $112.14 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $93.75 | 2025 | Fibryga |
| Haemonetics Corporation | $68.13 | 2023 | Teg6s Hemostasis System |
| Solventum Corporation | $63.08 | 2025 | Activ.A.C., Prevena |
| Bolton Medical INC | $48.06 | 2022 | |
| Argon Medical Devices, INC. | $44.85 | 2025 | Clot Management |
| Limflow INC. | $33.87 | 2023 | Limflow System |
| Imperative Care, INC | $28.27 | 2025 | Symphony Catheter |
| Janssen Biotech, INC. | $25.54 | 2025 | Tremfya |
| Cordis US Corp. | $21.54 | 2025 | Mynx Control Venous |
| Smith+Nephew, INC. | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Decarlo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.